Description du projet
Soutenir l’innovation biomédicale en Pologne
La Pologne a réalisé des progrès impressionnants en matière de découvertes scientifiques fondamentales au cours des 30 dernières années. Elle peine toutefois à les transposer en applications médicales. Financé par le programme Horizon Europe, le projet RACE entend combler cette lacune en renforçant les capacités de l’Institut international de biologie moléculaire et cellulaire de Varsovie (IIMCB). Le projet transformera l’IIMCB en un centre d’excellence de recherche translationnelle de classe mondiale dans le domaine de l’ARN et de la biologie cellulaire, encourageant des collaborations avec d’autres instituts de recherche dans toute l’Europe. RACE contribuera à la mise en place d’installations de base commercialement viables, à la mise en œuvre de stratégies de transfert de technologies et fournira un soutien administratif. Il concentrera l’ensemble ces initiatives dans le nouveau siège de l’IIMCB.
Objectif
Polish science, including biomedical research, has made huge advances in the last 30 years. However, the advancement of its fundamental scientific discoveries toward medical or commercial applications still lags behind the top countries, worldwide. This gap stems from the limited experience of Polish researchers in the field of translational research. The International Institute of Molecular and Cell Biology in Warsaw (IIMCB) aims to close this gap by building the capacity to translate basic knowledge into clinical innovations and by introducing an entrepreneurship culture in the scientific environment in Poland. Since its creation, the IIMCB has been a lighthouse of research and management excellence in Poland. Recognising the Institutes achievements and future potential, the Polish government awarded funding to build an expanded, modern IIMCB headquarters, which will increase our capacity up to 20 research groups. The RACE project under the Teaming programme will help us achieve this reality and successfully upgrade the IIMCB to a world-class translational research Centre of Excellence in RNA and Cell Biology. Together with our Advanced Partners, the Medical Research Council, Human Genetics Unit of the University of Edinburgh (UoEMRC HGU), and VIB in Belgium, we have identified five Specific Objectives that are key to achieve our goal, namely: recruitment and training of the next generation of entrepreneurial group leaders and researchers (Objectives 1, 2), establishment of modern and self-sustaining Core Facilities adapted to commercial use (Objective 3), implementation of systemic Technology Transfer (Objectives 4) and administrative support (Objective 5). Ultimately, the RACE project will make the IIMCB a reference model in translational research countrywide and elevate the Institute to the top tier of European research centres ready to engage in competitive EU and global biomedical research and innovation projects at the frontiers of science.
Mots‑clés
Programme(s)
Appel à propositions
(s’ouvre dans une nouvelle fenêtre) HORIZON-WIDERA-2022-ACCESS-01-two-stage
Voir d’autres projets de cet appelRégime de financement
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinateur
02109 Warszawa
Pologne